Calcium, a leading mid-sized healthcare marketing agency serving a variety of blue-chip life-science companies and brands, announced a financial partnership with NexPhase Capital to support its strategic growth plan.

Blackstone Group Inc. is investing $400 million in a joint venture with Swiss drug company Ferring that is working on an experimental gene therapy for bladder cancer, the private equity giant’s largest-ever bet on drug development.

Mallinckrodt plc agreed to sell the global biopharmaceutical company’s wholly owned subsidiary BioVectra Inc. to an affiliate of private equity investment firm H.I.G. Capital for $250 million.

In the wake of W2O being invested in by private equity firm New Mountain Capital, Med Ad News had a conversation with W2O CEO and founder Jim Weiss about the origins of the company, what makes it stand out from the competition, and how he wants to expand the company’s services.

Shares of Cambrex Corp. were up more than 46 percent in trading after the company announced an agreement to be acquired by an affiliate of the Permira funds for $60 per share, totaling $2.4 billion.

Nestle entered exclusive talks to sell the company’s skin health business to a consortium led by EQT Partners for 10.2 billion Swiss francs ($10.1 billion), as the food group shifts its portfolio in response to changing consumer demands.

Apollo Global Management will buy LifePoint Health in a $5.6 billion deal that will expand its rural U.S. hospitals business, the latest in a series of bets by private equity firms on healthcare.

Waltham, Mass.-based AMAG Pharmaceuticals will secure $530 million in cash as the company divests Cord Blood Registry to GI Partners, a private equity investment firm.

Paris-based Sanofi agreed to sell the company’s generics division Zentiva to the private equity firm Advent International for 1.9 billion euros ($2.4 billion). The deal is expected to wrap by year-end 2018.

Sanofi Genzyme, the French company’s rare-disease division based in Cambridge, Mass., announced it is laying off 130 people at a manufacturing facility in Boston.